
News &
Media
-
Neurotech International: NWR Virtual Healthcare Conference with Dr Thomas Duthy
-
Neurotech International Ltd Extends Rett Syndrome Study With Novel Cannabinoid Drug
-
Neurotech extends clinical trials for the $US2bn Rett Syndrome market
-
Neurotech International extends NTI164 Rett Syndrome trial to 52 weeks
-
Neurotech International receives HREC approval for cerebral palsy treatment trial
-
Neurotech International: Quarterly Investor Conference Call – Q4 FY23
Listen to the audio here | Time: 22.10
-
Neurotech International: Quarterly Investor Conference Call with Dr Thomas Duthy for the period ending 31 March 2023
Listen to the audio here | Time: 17.45
-
Small Caps Inverview: Neurotech International advances novel treatment for autism spectrum disorder
Watch the presentation here | Time: 22:15
-
NWR Virtual Healthcare Conference Presentation: Neurotech International Investor Presentation
Watch the presentation here | Time: 28:10